CereVasc, Inc. announced it has received its second FDA Breakthrough Device designation for the investigational eShunt system ...

Surmodics, Inc. announced the publication of results from the TRANSCEND clinical trial. The global randomized study demonstrat ...

Vivasure Medical, an Ireland-based developer of fully absorbable technology for percutaneous vessel closure, announced ...

R3 Vascular Inc. announced that the first patient was enrolled in the company’s ELITE-BTK pivotal trial evaluating its Magn ...

IceCure Medical Ltd. announced findings from three investigator-initiated studies of the company’s ProSense system for the ...

In an article published online in Journal of Vascular Surgery evaluating radiation dose exposure for vascular surgery ...

Venova Medical announced the completion of patient enrollment for the company’s VENOS-2 early feasibility study. Accordi ...

Aortic dissections are classified by site (Stanford type A, ascending aorta; type B, descending aorta) and chronicity (acute if onset of symptoms 2 weeks, chronic if > 2 weeks). The acute group can ...

Venous return is attained through a complex interaction of valves, muscle pumps, and pressure gradients and is greatly influenced by position. In the upright position, gravity is counteracted by the ...

Jetstream® aspirating revascularization technology (Pathway Medical Technologies, Inc., Kirkland WA) was initialized by a team of engineers who believed there was a definite need for a single device ...

Endovascular revascularization of patients with PVD has evolved dramatically, and we now have a better understanding of the atherosclerotic process. Traditionally, therapy has been delivered through ...

Multiple factors, rather than a single process, are implicated in the pathogenesis of TAA. Whereas abdominal aneurysms are characterized by severe intimal atherosclerosis, chronic transmural ...